Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 163

1.

Project Extension for Community Healthcare Outcomes (ECHO) in Multiple Sclerosis: Increasing Clinician Capacity.

Johnson KL, Hertz D, Stobbe G, Alschuler K, Kalb R, Alexander KS, Kraft GH, Scott JD.

Int J MS Care. 2017 Nov-Dec;19(6):283-289. doi: 10.7224/1537-2073.2016-099.

2.

Effect of Cognitive Demand on Functional Mobility in Ambulatory Individuals with Multiple Sclerosis.

Ciol MA, Matsuda PN, Khurana SR, Cline MJ, Sosnoff JJ, Kraft GH.

Int J MS Care. 2017 Jul-Aug;19(4):217-224. doi: 10.7224/1537-2073.2016-120.

3.

Rehabilitation in multiple sclerosis: Commentary on the recent AAN systematic review.

Haselkorn JK, Hughes C, Rae-Grant A, Jung Henson L, Bever CT, Lo AC, Brown TR, Kraft GH, Gronseth G, Armstrong MJ, Narayanaswami P.

Neurol Clin Pract. 2017 Jun;7(3):189-190. doi: 10.1212/01.CPJ.0000520916.56328.f5. No abstract available.

4.

High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS.

Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Steinmiller KC, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stuve O, Arnold DL, Wener MH, Georges GE, Wundes A, Kraft GH, Bowen JD.

Neurology. 2017 Feb 28;88(9):842-852. doi: 10.1212/WNL.0000000000003660. Epub 2017 Feb 1.

5.

Brain pathology of a patient 7years after autologous hematopoietic stem cell transplantation for multiple sclerosis.

Wundes A, Bowen JD, Kraft GH, Maravilla KR, McLaughlin B, von Geldern G, Georges G, Nash RA, Lu JQ.

J Neurol Sci. 2017 Feb 15;373:339-341. doi: 10.1016/j.jns.2017.01.016. Epub 2017 Jan 7.

PMID:
28131217
6.

Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Jones DE, Sutliff MH, Halper J, Armstrong MJ, Brown TR, Haselkorn JK, Kraft GH, Narayanaswami P.

Neurology. 2016 Aug 9;87(6):646. doi: 10.1212/01.wnl.0000491123.28224.44. No abstract available.

PMID:
27502965
7.

An Empirical Investigation of a Biopsychosocial Model of Pain in Multiple Sclerosis.

Day MA, Ehde DM, Ward LC, Hartoonian N, Alschuler KN, Turner AP, Kraft GH, Jensen MP.

Clin J Pain. 2016 Feb;32(2):155-63. doi: 10.1097/AJP.0000000000000240.

PMID:
26741742
8.

Use of Neurofeedback to Enhance Response to Hypnotic Analgesia in Individuals With Multiple Sclerosis.

Jensen MP, Gianas A, George HR, Sherlin LH, Kraft GH, Ehde DM.

Int J Clin Exp Hypn. 2016;64(1):1-23. doi: 10.1080/00207144.2015.1099400.

PMID:
26599991
9.

Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Haselkorn JK, Hughes C, Rae-Grant A, Henson LJ, Bever CT, Lo AC, Brown TR, Kraft GH, Getchius T, Gronseth G, Armstrong MJ, Narayanaswami P.

Neurology. 2015 Nov 24;85(21):1896-903. doi: 10.1212/WNL.0000000000002146. Review.

10.

Cross-Sectional Examination of the Associations Between Symptoms, Community Integration, and Mental Health in Multiple Sclerosis.

Kratz AL, Ehde DM, Hanley MA, Jensen MP, Osborne TL, Kraft GH.

Arch Phys Med Rehabil. 2016 Mar;97(3):386-94. doi: 10.1016/j.apmr.2015.10.093. Epub 2015 Oct 31.

11.

Utilization and patients' perceptions of the effectiveness of pain treatments in multiple sclerosis: A cross-sectional survey.

Ehde DM, Alschuler KN, Osborne TL, Hanley MA, Jensen MP, Kraft GH.

Disabil Health J. 2015 Jul;8(3):452-6. doi: 10.1016/j.dhjo.2015.03.001. Epub 2015 Mar 14.

12.

Pain affects depression through anxiety, fatigue, and sleep in multiple sclerosis.

Amtmann D, Askew RL, Kim J, Chung H, Ehde DM, Bombardier CH, Kraft GH, Jones SM, Johnson KL.

Rehabil Psychol. 2015 Feb;60(1):81-90. doi: 10.1037/rep0000027. Epub 2015 Jan 19.

13.

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report.

Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stüve O, Arnold DL, Spychala ME, McConville KC, Harris KM, Phippard D, Georges GE, Wundes A, Kraft GH, Bowen JD.

JAMA Neurol. 2015 Feb;72(2):159-69. doi: 10.1001/jamaneurol.2014.3780.

14.

Assessment of upper extremity function in multiple sclerosis: review and opinion.

Kraft GH, Amtmann D, Bennett SE, Finlayson M, Sutliff MH, Tullman M, Sidovar M, Rabinowicz AL.

Postgrad Med. 2014 Sep;126(5):102-8. doi: 10.3810/pgm.2014.09.2803. Review.

PMID:
25295653
15.

Improved physical fitness correlates with improved cognition in multiple sclerosis.

Beier M, Bombardier CH, Hartoonian N, Motl RW, Kraft GH.

Arch Phys Med Rehabil. 2014 Jul;95(7):1328-34. doi: 10.1016/j.apmr.2014.02.017. Epub 2014 Mar 4.

PMID:
24607835
16.

Self-management for people with multiple sclerosis: report from the first international consensus conference, november 15, 2010.

Fraser R, Ehde D, Amtmann D, Verrall A, Johnson KL, Johnson E, Kraft GH.

Int J MS Care. 2013 Summer;15(2):99-106. doi: 10.7224/1537-2073.2012-044.

17.

Multiple sclerosis rehabilitation.

Johnson SL, Kraft GH.

Phys Med Rehabil Clin N Am. 2013 Nov;24(4):xvii-xviii. doi: 10.1016/j.pmr.2013.07.004. Epub 2013 Aug 6. No abstract available.

PMID:
24314695
18.

Future directions of multiple sclerosis rehabilitation research.

Kraft GH, Johnson KL, Amtmann D, Bamer AM, Bombardier CH, Ehde DM, Fraser R, Verrall AM, Yorkston K.

Phys Med Rehabil Clin N Am. 2013 Nov;24(4):721-30. doi: 10.1016/j.pmr.2013.06.005. Epub 2013 Aug 3. Review.

PMID:
24314689
19.

Evoked potentials in multiple sclerosis.

Kraft GH.

Phys Med Rehabil Clin N Am. 2013 Nov;24(4):717-20. doi: 10.1016/j.pmr.2013.07.001. Review.

PMID:
24314688
20.

Multiple sclerosis and fatigue: understanding the patient's needs.

Cook KF, Bamer AM, Roddey TS, Kraft GH, Kim J, Amtmann D.

Phys Med Rehabil Clin N Am. 2013 Nov;24(4):653-61. doi: 10.1016/j.pmr.2013.06.006. Epub 2013 Sep 3.

Supplemental Content

Loading ...
Support Center